Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
As of Jun. 2026, Manac Chemical Partners Co has a Sloan Ratio of 6.14%, indicating the company is in the safe zone and there is no funny business with accruals.
Manac Chemical Partners Co (TSE:4360) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Jun. 2026, Manac Chemical Partners Co has a Sloan Ratio of 6.14%, indicating the company is in the safe zone and there is no funny business with accruals.
Manac Chemical Partners Co Sloan Ratio % Related Terms
Manac Chemical Partners Co Sloan Ratio % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Manac Chemical Partners Co's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Manac Chemical Partners Co Sloan Ratio % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Manac Chemical Partners Co's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Manac Chemical Partners Co's Sloan Ratio % falls into.
Manac Chemical Partners Co Sloan Ratio % Calculation
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Manac Chemical Partners Co's Net Income for the trailing twelve months (TTM) ended in Jun. 2026 was 378 (Sep. 2025 ) + 138 (Dec. 2025 ) + 179 (Mar. 2026 ) + 289 (Jun. 2026 ) = 円984 Mil.
Manac Chemical Partners Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was (Sep. 2025 ) + (Dec. 2025 ) + (Mar. 2026 ) + (Jun. 2026 ) = 円0 Mil.
Manac Chemical Partners Co's Cash Flow from Investing for the trailing twelve months (TTM) ended in Jun. 2026 was (Sep. 2025 ) + (Dec. 2025 ) + (Mar. 2026 ) + (Jun. 2026 ) = 円0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Manac Chemical Partners Co (TSE:4360) has a Sloan Ratio % of 6.14% as of Jun. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Manac Chemical Partners Co and its competitors.
Is Manac Chemical Partners Co's Sloan Ratio % too high?
Manac Chemical Partners Co's current Sloan Ratio % is 6.14%. Overall, Manac Chemical Partners Co has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Manac Chemical Partners Co's Sloan Ratio % compare to DOW?
Manac Chemical Partners Co's Sloan Ratio % of 6.14% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Chemicals company?
A good Sloan Ratio % depends on the Chemicals industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Manac Chemical Partners Co and its competitors. Manac Chemical Partners Co's current Sloan Ratio % is 6.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Manac Chemical Partners Co stock overvalued right now?
Based on GuruFocus' analysis, Manac Chemical Partners Co (TSE:4360) is currently considered Significantly Overvalued. The stock's GF Value™ is 円602.34, compared to a current price of 円992.00 — trading 64.7% above its estimated fair value. The current Sloan Ratio % is 6.14%. Manac Chemical Partners Co's overall GF Score™ is 57/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Manac Chemical Partners Co (TSE:4360), the current Sloan Ratio % is 6.14% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Manac Chemical Partners Co (TSE:4360) Overvalued in 2026?
Based on GuruFocus' analysis, Manac Chemical Partners Co stock appears to be overvalued.
The current stock price of 円992.00 is trading 64.7% above its estimated GF Value™ of 円602.34.
GuruFocus considers Manac Chemical Partners Co to be Significantly Overvalued.
Key valuation signals for TSE:4360:
Sloan Ratio %: 6.14%
GF Value™: 円602.34 vs. price of 円992.00 (64.7% above fair value)
No single metric tells the full story. See the TSE:4360 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Manac Chemical Partners Co Ltd is engaged in the manufacture and sale of various chemical products, pharmaceuticals, and the manufacture and sale of animal medicines.
57GF Score
Get the complete analysis for TSE:4360
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4360 has been successfully added to your 
